Immunitrack is a spinout from the University of Copenhagen that gathers more than 10 years of experience in production how highly valued biomolecules and highly accurate assays that can measure immunogenicity of peptides. Immunitrack has already generated incomes through fee for services, that include sales of biomolecules for 200 000 dkk and assay measurements for 600 000 dkk. Worlwide competition only includes 4 players. An investment of 2.5 million Dkk over 2 years would enable Immunitrack to increase its production capacities and increase customer base and visbility which are needed to reach full growth potential of the company.